HCA’s $1.8M Lobbying Blitz Protects Junk Fees by Taxing American Seniors

In April 2026, HCA Healthcare filed LD-2 disclosures revealing a $1.8 million lobbying expenditure for the first quarter of the year. This targeted financial campaign was aimed at a singular legislative threat: the 2026 Medicare Transparency Act. Specifically, HCA sought to neutralize 'Site Neutral' payment provisions that would have eliminated the 'facility fees' hospitals charge for routine outpatient services. Records show the lobbying was successful. The final version of the bill, recently advanced by the House Ways and Means Subcommittee on Health, includes a 48-month delay for the implementation of these cost-saving measures, a move that effectively preserves billions in revenue for the nation’s largest for-profit hospital operator.

[Facility Fees] are overhead charges hospitals add to outpatient bills, often doubling the cost of services like colonoscopies or scans without providing additional medical care. According to data from the Peterson-KFF Health System Tracker, these fees allow hospitals to charge significantly more for the exact same procedure performed in a hospital-owned clinic compared to an independent physician’s office. For a standard outpatient visit, a facility fee can add between $150 and $450 to a patient's bill before a single medical instrument is used.

The money trail leads directly to the 12 members of the House Ways and Means Subcommittee on Health who voted to insert the four-year delay into the legislation. Federal Election Commission (FEC) filings show that these 12 representatives received a combined $245,000 in PAC contributions from HCA Healthcare during the same quarter the bill was being drafted and marked up. While the 2026 Medicare Transparency Act was originally designed to provide immediate relief to seniors, the revised timeline ensures that HCA and its competitors can continue to collect these inflated fees through the end of the decade.

[Site Neutral Payments] is a policy requiring Medicare to pay the same amount for a medical service regardless of the setting, ensuring that taxpayers and patients do not pay a premium simply because a doctor's office is owned by a hospital system. The non-partisan Medicare Payment Advisory Commission (MedPAC) has repeatedly recommended site-neutral payments, estimating that the reform would save the Medicare program over $100 billion over a decade. However, for-profit entities like HCA Healthcare, led by CEO Sam Hazen, have fought these reforms to protect their outpatient margins. In 2025, HCA reported a net income exceeding $5 billion, yet the company’s lobbying narrative focused heavily on the risk to 'safety net' hospitals.

Mainstream media coverage of the Medicare Transparency Act has largely mirrored the talking points of the American Hospital Association (AHA). Outlets have reported on industry 'concerns' that site-neutral payments would force rural clinic closures and destabilize the healthcare infrastructure. What these reports leave out is the specific financial windfall the 48-month delay provides. By Gen Us calculations based on HCA’s 2025 outpatient revenue filings, a four-year delay in site-neutral implementation represents an estimated $2.4 billion in continued revenue that would otherwise have been eliminated by the reform.

This influence is bolstered by a 'revolving door' between the regulators and the regulated. Our investigation found that three former senior staffers who previously served on the House Ways and Means Subcommittee on Health are now employed by the lobbying firms hired by HCA Healthcare for this specific Q1 2026 campaign. These individuals possess intimate knowledge of the subcommittee’s internal processes and personal relationships with current members, providing HCA with a direct channel to shape the legislative text.

[Regulatory Capture] occurs when a government agency or legislative body, created to act in the public interest, instead prioritizes the commercial or political interests of the industry it is charged with overseeing. The subcommittee’s decision to delay site-neutral payments, despite overwhelming evidence of the policy’s benefit to the public, serves as a textbook example of this phenomenon.

For ordinary people, this legislative pivot has immediate and tangible costs. A Medicare beneficiary undergoing a routine screening at an HCA-owned clinic will continue to pay an out-of-pocket 'facility fee' that serves no clinical purpose. While the hospital industry frames the delay as a necessary protection for healthcare access, the reality is a transfer of wealth from elderly patients and the federal treasury to the balance sheets of a Fortune 100 corporation. The $1.8 million HCA spent on lobbyists in Q1 was not an expense; it was an investment with a 1,300-fold return in preserved revenue.

As the bill moves to the full House floor, the 48-month delay remains the primary obstacle to lowering healthcare costs for millions of Americans. Use the Gen Us Politician Tracker to see if your representative took money from HCA Healthcare's PAC and how they voted on the Medicare Transparency Act amendments. We have also uploaded the full list of HCA’s Q1 lobbying disclosures to our document database for public review.